Extended En Bloc Reoperation for Recurrent or Persistent Parathyroid Carcinoma: Analysis of 31 Cases in a Single Institute Experience

被引:19
作者
Wei, Bojun [1 ]
Zhao, Teng [1 ]
Shen, Hong [1 ]
Jin, Mulan [2 ]
Zhou, Quan [3 ]
Liu, Xing [1 ]
Wang, Jiacheng [1 ]
Wang, Qian [1 ]
机构
[1] Capital Med Univ, Dept Thyroid & Neck Surg, Beijing Chaoyang Hosp, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China
关键词
PROGNOSTIC-FACTORS; GUIDELINES; MANAGEMENT; DIAGNOSIS; CANCER; UPDATE;
D O I
10.1245/s10434-021-10962-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Parathyroid carcinoma (PC) is a rare malignancy that is difficult to eradicate completely after recurrence. We assessed the efficiency of extended en bloc resection (EEBR) in the management of recurrent or persistent PC. Methods In this observational cohort study, 31 patients who underwent reoperations for recurrent or persistent PC were enrolled after 2-9 surgeries by other medical teams. EEBRs, which provided the oncologic resection by removing all possible tumor-bearing scar tissues, were adopted in 25 patients. The other 6 with gross infiltration into the upper aerodigestive tract (UAT) underwent less radical procedures for unwillingness to sacrifice laryngeal function. Results The 5-year overall survival (OS) rate after EEBR was 59.6% compared with 16.7% after less radical procedures, with an improved median expected survival time of 90.0 months compared with 13.0 months after local excision. EEBR exhibited a favorable local control of relapses in 84.0% of patients after a median follow-up period of 27.0 months, 40.0% even achieved disease-free survival, although 56.0% had subsequent distant metastases (DMs) and suffered a worse 5-year OS of 36.7% in contrast with 100.0% in the absence of DM (p = 0.011). UAT invasion, rather than age, number of previous operations, or preoperative PTH levels, was the unique independent factor associated with both DM (HR = 5.466, p = 0.006) and mortality (HR = 7.606, p = 0.011). Conclusion EEBRs provide better outcomes than other conventional surgical approaches and might offer a second chance of cure for patients with recurrent or persistent PC in the absence of DM.
引用
收藏
页码:1208 / 1215
页数:8
相关论文
共 19 条
  • [11] Lymph Node Involvement and Surgical Approach in Parathyroid Cancer
    Schulte, Klaus-Martin
    Talat, Nadia
    Miell, John
    Moniz, Caje
    Sinha, Prakash
    Diaz-Cano, Salvador
    [J]. WORLD JOURNAL OF SURGERY, 2010, 34 (11) : 2611 - 2620
  • [12] Parathyroid carcinoma
    Shane, E
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 485 - 493
  • [13] Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma
    Silva-Figueroa, Angelica M.
    Hess, Kenneth R.
    Williams, Michelle D.
    Clarke, Callisia N.
    Christakis, Ioannis
    Graham, Paul H.
    Grubbs, Elizabeth G.
    Lee, Jeffrey E.
    Busaidy, Naifa L.
    Perrier, Nancy D.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 224 (05) : 980 - 987
  • [14] Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma
    Silverberg, S. J.
    Rubin, M. R.
    Faiman, C.
    Peacock, M.
    Shoback, D. M.
    Smallridge, R. C.
    Schwanauer, L. E.
    Olson, K. A.
    Klassen, P.
    Bilezikian, J. P.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (10) : 3803 - 3808
  • [15] Clinical Presentation, Staging and Long-Term Evolution of Parathyroid Cancer
    Talat, Nadia
    Schulte, Klaus-Martin
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (08) : 2156 - 2174
  • [16] Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases
    Wang, Peisong
    Xue, Shuai
    Wang, Shuo
    Lv, Zhi
    Meng, Xianying
    Wang, Guimin
    Meng, Wei
    Liu, Jia
    Chen, Guang
    [J]. ONCOLOGY LETTERS, 2017, 14 (06) : 7276 - 7282
  • [17] Parathyroid Carcinoma: Update and Guidelines for Management
    Wei, Christina H.
    Harari, Avital
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) : 11 - 23
  • [18] The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
    Wilhelm, Scott M.
    Wang, Tracy S.
    Ruan, Daniel T.
    Lee, James A.
    Asa, Sylvia L.
    Duh, Quan-Yang
    Doherty, Gerard M.
    Herrera, Miguel F.
    Pasieka, Janice L.
    Perrier, Nancy D.
    Silverberg, Shonni J.
    Solorzano, Carmen C.
    Sturgeon, Cord
    Tublin, Mitchell E.
    Udelsman, Robert
    Carty, Sally E.
    [J]. JAMA SURGERY, 2016, 151 (10) : 959 - 968
  • [19] Preoperative diagnosis and prognosis in 40 Parathyroid Carcinoma Patients
    Xue, Song
    Chen, Haizhen
    Lv, Chunhui
    Shen, Xiaohui
    Ding, Jiazeng
    Liu, Jianmin
    Chen, Xi
    [J]. CLINICAL ENDOCRINOLOGY, 2016, 85 (01) : 29 - 36